Neurology is a branch of medicine which deals with nervous system disorders. Neurology deals with the treatment and diagnosis of all types of disorders related to the peripheral and the central nervous system. Pediatric neurology refers to the diagnosis and treatment of neurological disorders specifically in pediatric patients. Pediatric neurological disorders include muscular dystrophy, epilepsy, and paroxysmal disorders. There are various age groups considered in a pediatric patient pool such as infants, children, neonates, and adolescents. The neonates are considered newborn infant, infants are referred in age group up to two years. The adolescents are considered in the age range of 10 years to 19 years. The pediatric neurology market comprises few medical devices such as EEG (electroencephalogram) and brain stimulation devices, which are used in the diagnosis and treatment of pediatric neurological disorders. There are various therapies available for the treatment of pediatric neurological disorders such as intrathecal drug therapies, lumbar puncture therapies, and pediatric neurological evaluations. Currently, there is growing extensive research and development with a significant number of new product introduction in the market. This caters to the increasing patient demand for efficient and effective treatment modality. The pediatric neurology is a consolidated market, with significant market shares held by top industry players such as Medtronic, Elana Inc. Courtagen, and Ethicon. Most of the companies are emphasizing on research and development activities toward novel drug development, which in turn is contributing to the market growth for pediatric neurology. In addition, high unmet needs for curative treatment of pediatric neurological disorders are likely to present a significant market opportunity. Growth of the global pediatric neurology market is projected to be driven by emerging economies in Asia, where the prevalence of the disorder is comparatively high as compared to other regions.
According to a report published by UMKC School of Medicine, about 2.7 million people in the U.S. have epilepsy and more than 45,000 new cases are diagnosed every year. Epilepsy is more common than multiple sclerosis, cerebral palsy, and Parkinson’s disease combined. Rising incidence and prevalence of neurological disorders in pediatric patient pool explains the need for treatment of neurological disorders in the region, and thereby increases the market potential for neurology drugs. Therefore, rising incidence of neurological disorders is a major factor driving the global pediatric neurology market. In addition, rising demand for advanced diagnosis and treatment of neurological disorders, intra-industry competition, and increasing new entrants are boosting the market growth.
The global pediatric neurology market has been segmented based on age group, service and treatment, subspecialty, and region. Based on age group, the global pediatric neurology market has been segmented into infants, neonates, children, and adolescents. Based on service and treatment, the market has been segmented into intrathecal drug therapy, electroencephalogram, lumbar puncture, neurological evaluation, and vagal nerve stimulation. Based on subspecialty, the market has been segmented into neuromuscular, neurooncology, neuroimmunology, stroke, neonatal neurology, and others.
Geographically, the pediatric neurology market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to account for the highest share of the pediatric neurology market during the forecast period, followed by Europe and Asia Pacific. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period. Globally, market players involved in the pediatric neurology treatment and services have implemented new strategies and technological advancements. In terms of country, the U.S. dominates the pediatric neurology market with a significant market share, followed by the U.K. New launch of pediatric neurology devices worldwide is projected to drive the growth of the market.
Major players operating in the global pediatric neurology market include Medtronic, Elana Inc., Courtagen, Ethicon, Nemours, and Inova Health System.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.